Ensure Patients Get Recommended Meningococcal Vaccines

Questions will crop up about who needs meningococcal vaccines...due to new CDC guidelines.

Keep in mind, about 15% of meningococcal infections are fatal...and up to 20% result in long-term complications, such as brain damage.

Continue to give a dose of quadrivalent meningococcal vaccine (Menactra, Menveo) at age 11 or 12 plus a booster at age 16...to cover serogroups A, C, W, and Y.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote